Global Health Diagnostics | June 3-5, 2024

“I enjoyed the format of the presentations…very effective in terms of absorbing the information and then being able to generate fruitful discussion that involved multiple speakers' opinions. The topics covered were very relevant to the current diagnostics landscape, and the speakers each discussed topics that fit very well together.”

-Global Health Diagnostics course participant

COURSE FORMAT

Hybrid. ***DATE CHANGE***  The course will be live to both the in-person and online participants approximately 9:00am-3:00pm (Montreal time) each day June 3-5, 2024. All content will be recorded and accessible to participants until July 1, 2024.

DESCRIPTION

This three-day seminar on global health diagnostics will focus on cross-cutting issues (implementation, evidence, policy and guidance, cost effectiveness, data harmonization, artificial intelligence) in the infectious diseases diagnostics space, spanning antimicrobial resistance (AMR), acute febrile illnesses, neglected tropical diseases (NTDs), sexually transmitted and blood borne infections (HIV/STBBIs), TB, and Malaria.

Participants will learn from experts and stakeholders including policy makers, academics, clinicians, researchers, community advocates, program managers, product manufacturers, donors, product development partnerships, public health implementers and health leaders from high-burden countries. Attendees can expect a mix of plenary talks, engaging panel discussions and tech pitches from industry leaders.

Note May 31st: Enrollment is closed for this course.

COURSE DIRECTORS

Nitika Pant Pai, MD, MPH, PhD
Associate Professor, Division of Clinical Epidemiology, Experimental Medicine & Infectious Diseases, McGill University;
Center for Outcomes Research and Evaluation, MUHC Research Institute

Cédric Yansouni, MD, FRCPC, DTM&H
Associate Professor, Divisions of Infectious Diseases and Medical Microbiology, McGill University Health Centre;
Associate Director, J.D. MacLean Centre for Tropical and Geographic Medicine

Watch the video to hear the Drs. Pai and Yansouni discuss the course!

PREVIOUS COURSE FACULTY

• Sue Horton – University of Waterloo
• Tanya Applegate – Kirby Institute, Australia
• Sarah Charnaud – WHO
• Wallace White – FIND
• Michael Mina – eMed
• Marguerite Massinga Loembe – Africa CDC
• Collins Otieno – ASLM
• Trevor Peter – Clinton Health Access Initiative
• Christine Leckie – Health Canada
• Ali Esmail – University of Cape Town
• Mikashmi Kohli – FIND
• Ricky Janssen – Maastricht University
• Jesse Papenburg – McGill University
• Ameeta Singh – University of Alberta
• Christine Mesa – National Microbiology Laboratory, Canada

Faculty are still being confirmed and there may be changes to the above list.

CONTENT

Infectious diseases continue to pose a major threat to the health of most developing nations. The COVID-19 pandemic and emergence and spread of infections like XDR-TB, Ebola, dengue, chikungunya, and avian influenza have highlighted the importance of effective global response to epidemic threats.

Diagnosis is a critical step in effective disease care and control, but many people in developing countries do not have access to high quality diagnostic tests.

In this popular course, professionals ranging from clinicians, nurses, policy-makers, researchers, implementers, advocates and health educators gather to share their rich and diverse experiences, successes, failures and lessons learned in launching, leading, important diagnostic initiatives, globally.

OBJECTIVES

• Create a space for information exchange and knowledge transfer in global health diagnostics that energizes those working and studying in the field.
• Inform, educate, and convene discussions on current issues in global health diagnostics to guide the direction of future practice, policy, and funding initiatives for diagnostics.
• Dissect the value chain for global health diagnostics development, current pipeline of diagnostics, market size and dynamics, policies on diagnostics, and barriers for scale-up for selected infectious diseases of global health importance across all infections.
• Debate and propose solutions for accelerating market entry for innovative diagnostics, to sustain and support manufacturers’ engagement in development of new diagnostics that address unmet global health needs.
• Debate and identify novel approaches to scale-up, including innovative business models that leverage market-based incentives.

TARGET AUDIENCE

This course appeals to a wide range of participants including:

• Policy makers and ministry officials
• Researchers, academics, and students/fellows studying global health or infectious disease
• Product developers, and industry
• Funders and public health agency officials
• Community advocacy groups working in diagnostics and global health

ENROLMENT

Limited to 100 online participants and 100 in-person participants.